| Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the … V Conter, CR Bartram, MG Valsecchi, A Schrauder, R Panzer-Grümayer, ... Blood, The Journal of the American Society of Hematology 115 (16), 3206-3214, 2010 | 986 | 2010 |
| Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients … A Möricke, A Reiter, M Zimmermann, H Gadner, M Stanulla, ... Blood, The Journal of the American Society of Hematology 111 (9), 4477-4489, 2008 | 791 | 2008 |
| Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000 A Möricke, M Zimmermann, A Reiter, G Henze, A Schrauder, H Gadner, ... Leukemia 24 (2), 265-284, 2010 | 763 | 2010 |
| The MLL recombinome of acute leukemias in 2017 C Meyer, T Burmeister, D Gröger, G Tsaur, L Fechina, A Renneville, ... Leukemia 32 (2), 273-284, 2018 | 738 | 2018 |
| The MLL recombinome of acute leukemias in 2013 C Meyer, J Hofmann, T Burmeister, D Gröger, TS Park, M Emerenciano, ... Leukemia 27 (11), 2165-2176, 2013 | 589 | 2013 |
| Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international … T Flohr, A Schrauder, G Cazzaniga, R Panzer-Grümayer, ... Leukemia 22 (4), 771-782, 2008 | 537 | 2008 |
| Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias C Shochat, N Tal, OR Bandapalli, C Palmi, I Ganmore, G te Kronnie, ... Journal of Experimental Medicine 208 (5), 901-908, 2011 | 432 | 2011 |
| Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report … L Hertzberg, E Vendramini, I Ganmore, G Cazzaniga, M Schmitz, ... Blood, The Journal of the American Society of Hematology 115 (5), 1006-1017, 2010 | 412 | 2010 |
| Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome D Bercovich, I Ganmore, LM Scott, G Wainreb, Y Birger, A Elimelech, ... The Lancet 372 (9648), 1484-1492, 2008 | 408 | 2008 |
| Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance L Bonapace, BC Bornhauser, M Schmitz, G Cario, U Ziegler, FK Niggli, ... The Journal of clinical investigation 120 (4), 1310-1323, 2010 | 398 | 2010 |
| Estrogen metabolism and risk of breast cancer: a prospective study of the 2: 16α-hydroxyestrone ratio in premenopausal and postmenopausal women P Muti, HL Bradlow, A Micheli, V Krogh, JL Freudenheim, ... Epidemiology 11 (6), 635-640, 2000 | 389 | 2000 |
| Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia M Stanulla, E Schaeffeler, T Flohr, G Cario, A Schrauder, M Zimmermann, ... Jama 293 (12), 1485-1489, 2005 | 344 | 2005 |
| Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia S Breit, M Stanulla, T Flohr, M Schrappe, WD Ludwig, G Tolle, M Happich, ... Blood 108 (4), 1151-1157, 2006 | 338 | 2006 |
| Childhood cancer predisposition syndromes—a concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology T Ripperger, SS Bielack, A Borkhardt, IB Brecht, B Burkhardt, ... American journal of medical genetics Part A 173 (4), 1017-1037, 2017 | 324 | 2017 |
| Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk AL Sherborne, FJ Hosking, RB Prasad, R Kumar, R Koehler, ... Nature genetics 42 (6), 492-494, 2010 | 320 | 2010 |
| IKZF1plus Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia M Stanulla, E Dagdan, M Zaliova, A Möricke, C Palmi, G Cazzaniga, ... Journal of Clinical Oncology 36 (12), 1240-1249, 2018 | 302 | 2018 |
| Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000 A Möricke, M Zimmermann, MG Valsecchi, M Stanulla, A Biondi, G Mann, ... Blood, The Journal of the American Society of Hematology 127 (17), 2101-2112, 2016 | 293 | 2016 |
| Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non–high-risk precursor B-cell acute lymphoblastic leukemia in children … G Cario, M Zimmermann, R Romey, S Gesk, I Vater, J Harbott, ... Blood, The Journal of the American Society of Hematology 115 (26), 5393-5397, 2010 | 292 | 2010 |
| Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a … M Stanulla, M Schrappe, AM Brechlin, M Zimmermann, K Welte Blood, The Journal of the American Society of Hematology 95 (4), 1222-1228, 2000 | 286 | 2000 |
| The MLL recombinome of acute leukemias C Meyer, B Schneider, S Jakob, S Strehl, A Attarbaschi, S Schnittger, ... Leukemia 20 (5), 777-784, 2006 | 285 | 2006 |
Giovanni CazzanigaUniv Milano Bicocca - Fondazione Tettamantiایمیل تأیید شده در unimib.it